Host Fred Goldstein invites Ruby Singh, Senior Vice President of Education and Instruction and Brittany Henry, Director of Education Programs, with AMCP, to discuss the brand-new 3rd edition of the AMCP Fundamentals of Managed Care Pharmacy Training Program scheduled for release July 2023.
Press Release: From News&Views April 2019: The Biologics Price Competition and Innovation Act (BPCIA) of 2009 created an FDA approval pathway for biosimilars that aimed to expanded patient access to these more affordable therapies.
Managed care pharmacy and prescription drug coverage is a growing part of the American health care sector. AMCP launched the annual Access, Affordability, and Outcomes report to raise awareness of the existence, prevalence, and importance of managed care pharmacy.
AMCP CEO Blog: The White House made news last month with its blueprint to lower drug prices. But it's also important to note that biosimilars will play a crucial role in fostering competition and lowering costs.
AMCP comment letter on New Hampshire legislation on medication synhcronization.
AMCP comment letter on state legislation on medication synchronization.
AMCP comment letter on state legislation on biological products dispensed by pharmacists.
AMCP comment letter on state legislation on interchangeable biologic products.
AMCP comment letter on state legislation on interchangeable biologic products.
AMCP comment letter on state legislation on interchangeable biologic products.
AMCP comment letter on state legislation on pharmacist substitution of biologics.
AMCP comments on state legislation on substitution of biologics.